Ashley Gallagher, Associate Editor

Some function is partially restored once smokers kick the habit, results presented at the European Society of Cardiology Congress 2022 show.

Investigational targeted B-cell therapy demonstrates superior efficacy compared with teriflunomide, a commonly prescribed treatment for MS.

Analysis from the Johns Hopkins Children’s Center and University of Colorado indicates that cancellation of sports and a switch to virtual learning likely increased this risk.

Study evaluates efficacy, immunogenicity, safety of the product to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Device provides tailored relief to multiple pain areas and adds more treatment options for evolving conditions.

Analysis shows that myocarditis was the most commonly diagnosed condition associated with pediatric post-acute sequelae of SARS-CoV-2.

Additionally, approximately 70% who responded to the EnlivenHealth survey say that one-third or more of their revenue comes from individuals eligible for the government health insurance.

As more biosimilars and specialty generics enter the market next year, this could result in a shift in drug spending.

Analysis is based on previously reported data collected in March and April 2022, with the FDA granting emergency use authorization for individuals aged 6 months to 4 years on June 17.

Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.

Results also show that no association with an increased frequency of myocarditis, venous thromboembolism, or worsening HF in these individuals.

Danish analysis looks at the relationship between the therapy and cardiovascular adverse effects, particularly arrhythmias.

Executives from CVS Health said they have multiple pathways in achieving a push to establish primary care services, provider enablement, and home health.

Investigators also report that the therapy could mimic the efficacy of olanzapine but cancelled out the medication-induced weight gain, improving symptoms and outcomes.

A P79S ORF2 variant demonstrates reduced RNA copy numbers released in the supernatant and impaired the production of infectious disease particles, investigators said.

Investigators report that while lateral flow tests do not detect the start of infectiousness well, they can identify individuals who will not infect others and can safely leave isolation.

Dundee Pharmacy’s compliance packaging encourages patients to stay adherent to their medications.

The regulatory submission includes data from the MOMENTUM phase 3 clinical trial that met all primary and key second efficacy end points.

University of Minnesota Medical School Analysis shows comparison with fluvoxamine and ivermectin in a double-blinded, placebo-controlled, randomized study.

The American Heart Association includes 6 conditions and indicates that men’s and women’s experiences may differ.

Investigators used the FDA-approved concussions test i-STAT TBI Plasma and the company’s core laboratory Architect instrument.

The treatment regimen is first in more than 20 years to significantly improve outcomes in individuals with the fast-growing cancer, according to the company.

Investigators find that establishing immunity in the mucosal areas establishes a frontline defense against these diseases.

Analysis is based on functional magnetic resonance imaging to provide insight into the effective connectivity.

The drug also meets the key secondary endpoint of improved overall survival for treatment for individuals with HER2 positive unresectable and/or metastatic breast cancer.

Study results show a compound annual growth rate of 5.2% from $392.4 billion in revenue in 2021.

Investigators from University of Texas Health Science Center at Houston analyze data from individuals aged 5 to 18 years enrolled in the Texas CARES survey.

The meta-analysis reviews 38 available studies on the effects of cognitive, physical, and social activities on brain function.

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

Investigators aimed to determine how individuals with and without concomitant NSP differ in characteristics and in their perception of treatment responses to analgesics.